Disturbance of regulation of NO synthase activity by peptides of insulin family in rat skeletal muscles in streptozotocin model of neonatal type 2 diabetes mellitus

Dokl Biochem Biophys. 2010 May-Jun:432:123-5. doi: 10.1134/s1607672910030087.
No abstract available

MeSH terms

  • Animals
  • Animals, Newborn
  • Diabetes Mellitus, Experimental / enzymology*
  • Diabetes Mellitus, Type 2 / enzymology
  • Insulin / pharmacology*
  • Insulin-Like Growth Factor I / pharmacology
  • Isoproterenol / pharmacology
  • Male
  • Muscle, Skeletal / drug effects*
  • Muscle, Skeletal / enzymology*
  • Nitric Oxide Synthase / antagonists & inhibitors
  • Nitric Oxide Synthase / metabolism*
  • Nitric Oxide Synthase Type I
  • Nitric Oxide Synthase Type III / antagonists & inhibitors
  • Nitric Oxide Synthase Type III / metabolism
  • Rats
  • Rats, Wistar
  • Relaxin / pharmacology

Substances

  • Insulin
  • Insulin-Like Growth Factor I
  • Relaxin
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type I
  • Nitric Oxide Synthase Type III
  • Nos1 protein, rat
  • Nos3 protein, rat
  • Isoproterenol